In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis

被引:4
|
作者
Fatoki, Toluwase Hezekiah [1 ]
Chukwuejim, Stanley [1 ,2 ]
Udenigwe, Chibuike C. [3 ,4 ]
Aluko, Rotimi E. [2 ,5 ]
机构
[1] Fed Univ Oye Ekiti, Dept Biochem, PMB 373, Oye 371104, Nigeria
[2] Univ Manitoba, Dept Food & Human Nutr Sci, Winnipeg, MB R3T 2N2, Canada
[3] Univ Ottawa, Fac Hlth Sci, Sch Nutr Sci, Ottawa, ON K1H 8M5, Canada
[4] Univ Ottawa, Fac Sci, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada
[5] Univ Manitoba, Richardson Ctr Food Technol & Res, Winnipeg, MB R3T 2N2, Canada
关键词
amyotrophic lateral sclerosis; ALS; associated genes; hydrolysate peptides; pharmacokinetics; target prediction; metabolic; supplements; molecular docking; TRANSGENIC MOUSE MODEL; PROTECTS MOTOR-NEURONS; BLOOD-BRAIN-BARRIER; SPINAL-CORD; APOPTOSIS PROTEIN; CYCLOOXYGENASE-2; INHIBITION; GENE; XIAP; CLEAVAGE;
D O I
10.3390/ijms24065828
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyotrophic lateral sclerosis (ALS) is regarded as a fatal neurodegenerative disease that is featured by progressive damage of the upper and lower motor neurons. To date, over 45 genes have been found to be connected with ALS pathology. The aim of this work was to computationally identify unique sets of protein hydrolysate peptides that could serve as therapeutic agents against ALS. Computational methods which include target prediction, protein-protein interaction, and peptide-protein molecular docking were used. The results showed that the network of critical ALS-associated genes consists of ATG16L2, SCFD1, VAC15, VEGFA, KEAP1, KIF5A, FIG4, TUBA4A, SIGMAR1, SETX, ANXA11, HNRNPL, NEK1, C9orf72, VCP, RPSA, ATP5B, and SOD1 together with predicted kinases such as AKT1, CDK4, DNAPK, MAPK14, and ERK2 in addition to transcription factors such as MYC, RELA, ZMIZ1, EGR1, TRIM28, and FOXA2. The identified molecular targets of the peptides that support multi-metabolic components in ALS pathogenesis include cyclooxygenase-2, angiotensin I-converting enzyme, dipeptidyl peptidase IV, X-linked inhibitor of apoptosis protein 3, and endothelin receptor ET-A. Overall, the results showed that AGL, APL, AVK, IIW, PVI, and VAY peptides are promising candidates for further study. Future work would be needed to validate the therapeutic properties of these hydrolysate peptides by in vitro and in vivo approaches.
引用
收藏
页数:22
相关论文
共 50 条
  • [41] A novel hypothesis on metal dyshomeostasis and mitochondrial dysfunction in amyotrophic lateral sclerosis: Potential pathogenetic mechanism and therapeutic implications
    Nakagawa, Yutaka
    Yamada, Shizuo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 892
  • [42] A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis
    Zhong Zhao
    Dale J Lange
    Andrei Voustianiouk
    Donal MacGrogan
    Lap Ho
    Jason Suh
    Nelson Humala
    Meenakshisundaram Thiyagarajan
    Jun Wang
    Giulio M Pasinetti
    BMC Neuroscience, 7
  • [43] Amyotrophic Lateral Sclerosis: From Research to Therapeutic Attempts and Therapeutic Perspectives
    Contestabile, A.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (36) : 5655 - 5665
  • [44] Molecular Chaperones' Potential against Defective Proteostasis of Amyotrophic Lateral Sclerosis
    Kinger, Sumit
    Dubey, Ankur Rakesh
    Kumar, Prashant
    Jagtap, Yuvraj Anandrao
    Choudhary, Akash
    Kumar, Amit
    Prajapati, Vijay Kumar
    Dhiman, Rohan
    Mishra, Amit
    CELLS, 2023, 12 (09)
  • [45] Riluzole and Edavarone: The Hope Against Amyotrophic Lateral Sclerosis
    Rokade, Aditi V.
    Yelne, Pallavi
    Giri, Anamika
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
  • [46] In silico Exploration of the Therapeutic Potential of Alkaloids as Anti-infective Agents
    Rani, Nidhi
    Kumar, Praveen
    Walia, Aditya
    Singh, Randhir
    LETTERS IN DRUG DESIGN & DISCOVERY, 2024, 21 (15) : 3307 - 3318
  • [47] Screening of Natural Compounds Against SOD1 as a Therapeutic Target for Amyotrophic Lateral Sclerosis
    Pahal, Sonu
    Chaudhary, Amit
    Singh, Sangeeta
    LETTERS IN DRUG DESIGN & DISCOVERY, 2022, 19 (10) : 877 - 887
  • [48] Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis
    Meanti, Ramona
    Bresciani, Elena
    Rizzi, Laura
    Coco, Silvia
    Zambelli, Vanessa
    Dimitroulas, Anna
    Molteni, Laura
    Omeljaniuk, Robert J.
    Locatelli, Vittorio
    Torsello, Antonio
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (12) : 2376 - 2394
  • [49] The multifaceted role of kinases in amyotrophic lateral sclerosis: genetic, pathological and therapeutic implications
    Guo, Wenting
    Vandoorne, Tijs
    Steyaert, Jolien
    Staats, Kim A.
    Van Den Bosch, Ludo
    BRAIN, 2020, 143 : 1651 - 1673
  • [50] Impaired tissue barriers as potential therapeutic targets for Parkinson’s disease and amyotrophic lateral sclerosis
    Xin Fang
    Metabolic Brain Disease, 2018, 33 : 1031 - 1043